The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Anti-Restenosis Stents-Global Market Insights and Sales Trends 2025

Anti-Restenosis Stents-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1831884

No of Pages : 115

Ask Your Query
Synopsis
The global Anti-Restenosis Stents market size is expected to reach US$ 2164.9 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Anti-Restenosis Stents in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Anti-Restenosis Stents market. Cobalt-Chromium Alloy Stents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Magnesium Alloy Stents segment is estimated at % CAGR for the next seven-year period.
Drug-Eluting Stents (DES): The dominance of drug-eluting stents continues to grow. These stents are coated with medications that help inhibit cell proliferation and reduce the risk of restenosis.
Biodegradable Stents: Biodegradable stents are designed to dissolve over time, reducing the risk of long-term complications associated with permanent stents. These stents are gaining traction, especially for specific patient populations.
Bioresorbable Scaffolds: Bioresorbable scaffolds provide temporary support to blood vessels, slowly breaking down over time as the vessel heals. They are designed to address restenosis while allowing the vessel to return to its natural state.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Materials, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-Restenosis Stents, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-Restenosis Stents market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-Restenosis Stents market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-Restenosis Stents sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-Restenosis Stents covered in this report include Sono-Tek Corporation, Abbott Vascular, Advantec Vascular, B.Braun Melsengen AG, Biosensors, Biotronik, Blue Medical, Boston Scientific and DISA Vascular, etc.
The global Anti-Restenosis Stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sono-Tek Corporation
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Sahajanand Medical Technologies
J&J/Cordis
Global Anti-Restenosis Stents market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-Restenosis Stents market, Segment by Materials:
Cobalt-Chromium Alloy Stents
Magnesium Alloy Stents
Nitinol Stents
Other Materials
Global Anti-Restenosis Stents market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Materials, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti-Restenosis Stents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti-Restenosis Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Anti-Restenosis Stents Market Overview
1.1 Anti-Restenosis Stents Product Overview
1.2 Anti-Restenosis Stents Market Segment by Materials
1.2.1 Cobalt-Chromium Alloy Stents
1.2.2 Magnesium Alloy Stents
1.2.3 Nitinol Stents
1.2.4 Other Materials
1.3 Global Anti-Restenosis Stents Market Size by Materials
1.3.1 Global Anti-Restenosis Stents Market Size Overview by Materials (2018-2029)
1.3.2 Global Anti-Restenosis Stents Historic Market Size Review by Materials (2018-2023)
1.3.3 Global Anti-Restenosis Stents Forecasted Market Size by Materials (2024-2029)
1.4 Key Regions Market Size Segment by Materials
1.4.1 North America Anti-Restenosis Stents Sales Breakdown by Materials (2018-2023)
1.4.2 Europe Anti-Restenosis Stents Sales Breakdown by Materials (2018-2023)
1.4.3 Asia-Pacific Anti-Restenosis Stents Sales Breakdown by Materials (2018-2023)
1.4.4 Latin America Anti-Restenosis Stents Sales Breakdown by Materials (2018-2023)
1.4.5 Middle East and Africa Anti-Restenosis Stents Sales Breakdown by Materials (2018-2023)
2 Global Anti-Restenosis Stents Market Competition by Company
2.1 Global Top Players by Anti-Restenosis Stents Sales (2018-2023)
2.2 Global Top Players by Anti-Restenosis Stents Revenue (2018-2023)
2.3 Global Top Players by Anti-Restenosis Stents Price (2018-2023)
2.4 Global Top Manufacturers Anti-Restenosis Stents Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Restenosis Stents Market Competitive Situation and Trends
2.5.1 Anti-Restenosis Stents Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Restenosis Stents Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Restenosis Stents as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Restenosis Stents Market
2.8 Key Manufacturers Anti-Restenosis Stents Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Restenosis Stents Status and Outlook by Region
3.1 Global Anti-Restenosis Stents Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti-Restenosis Stents Historic Market Size by Region
3.2.1 Global Anti-Restenosis Stents Sales in Volume by Region (2018-2023)
3.2.2 Global Anti-Restenosis Stents Sales in Value by Region (2018-2023)
3.2.3 Global Anti-Restenosis Stents Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anti-Restenosis Stents Forecasted Market Size by Region
3.3.1 Global Anti-Restenosis Stents Sales in Volume by Region (2024-2029)
3.3.2 Global Anti-Restenosis Stents Sales in Value by Region (2024-2029)
3.3.3 Global Anti-Restenosis Stents Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti-Restenosis Stents by Application
4.1 Anti-Restenosis Stents Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Anti-Restenosis Stents Market Size by Application
4.2.1 Global Anti-Restenosis Stents Market Size Overview by Application (2018-2029)
4.2.2 Global Anti-Restenosis Stents Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anti-Restenosis Stents Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Restenosis Stents Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anti-Restenosis Stents Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anti-Restenosis Stents Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anti-Restenosis Stents Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anti-Restenosis Stents Sales Breakdown by Application (2018-2023)
5 North America Anti-Restenosis Stents by Country
5.1 North America Anti-Restenosis Stents Historic Market Size by Country
5.1.1 North America Anti-Restenosis Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti-Restenosis Stents Sales in Volume by Country (2018-2023)
5.1.3 North America Anti-Restenosis Stents Sales in Value by Country (2018-2023)
5.2 North America Anti-Restenosis Stents Forecasted Market Size by Country
5.2.1 North America Anti-Restenosis Stents Sales in Volume by Country (2024-2029)
5.2.2 North America Anti-Restenosis Stents Sales in Value by Country (2024-2029)
6 Europe Anti-Restenosis Stents by Country
6.1 Europe Anti-Restenosis Stents Historic Market Size by Country
6.1.1 Europe Anti-Restenosis Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti-Restenosis Stents Sales in Volume by Country (2018-2023)
6.1.3 Europe Anti-Restenosis Stents Sales in Value by Country (2018-2023)
6.2 Europe Anti-Restenosis Stents Forecasted Market Size by Country
6.2.1 Europe Anti-Restenosis Stents Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti-Restenosis Stents Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti-Restenosis Stents by Region
7.1 Asia-Pacific Anti-Restenosis Stents Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Restenosis Stents Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti-Restenosis Stents Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anti-Restenosis Stents Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anti-Restenosis Stents Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Restenosis Stents Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti-Restenosis Stents Sales in Value by Region (2024-2029)
8 Latin America Anti-Restenosis Stents by Country
8.1 Latin America Anti-Restenosis Stents Historic Market Size by Country
8.1.1 Latin America Anti-Restenosis Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti-Restenosis Stents Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anti-Restenosis Stents Sales in Value by Country (2018-2023)
8.2 Latin America Anti-Restenosis Stents Forecasted Market Size by Country
8.2.1 Latin America Anti-Restenosis Stents Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti-Restenosis Stents Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti-Restenosis Stents by Country
9.1 Middle East and Africa Anti-Restenosis Stents Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Restenosis Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti-Restenosis Stents Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anti-Restenosis Stents Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anti-Restenosis Stents Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Restenosis Stents Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti-Restenosis Stents Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sono-Tek Corporation
10.1.1 Sono-Tek Corporation Company Information
10.1.2 Sono-Tek Corporation Introduction and Business Overview
10.1.3 Sono-Tek Corporation Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sono-Tek Corporation Anti-Restenosis Stents Products Offered
10.1.5 Sono-Tek Corporation Recent Development
10.2 Abbott Vascular
10.2.1 Abbott Vascular Company Information
10.2.2 Abbott Vascular Introduction and Business Overview
10.2.3 Abbott Vascular Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Vascular Anti-Restenosis Stents Products Offered
10.2.5 Abbott Vascular Recent Development
10.3 Advantec Vascular
10.3.1 Advantec Vascular Company Information
10.3.2 Advantec Vascular Introduction and Business Overview
10.3.3 Advantec Vascular Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Advantec Vascular Anti-Restenosis Stents Products Offered
10.3.5 Advantec Vascular Recent Development
10.4 B.Braun Melsengen AG
10.4.1 B.Braun Melsengen AG Company Information
10.4.2 B.Braun Melsengen AG Introduction and Business Overview
10.4.3 B.Braun Melsengen AG Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.4.4 B.Braun Melsengen AG Anti-Restenosis Stents Products Offered
10.4.5 B.Braun Melsengen AG Recent Development
10.5 Biosensors
10.5.1 Biosensors Company Information
10.5.2 Biosensors Introduction and Business Overview
10.5.3 Biosensors Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Biosensors Anti-Restenosis Stents Products Offered
10.5.5 Biosensors Recent Development
10.6 Biotronik
10.6.1 Biotronik Company Information
10.6.2 Biotronik Introduction and Business Overview
10.6.3 Biotronik Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Biotronik Anti-Restenosis Stents Products Offered
10.6.5 Biotronik Recent Development
10.7 Blue Medical
10.7.1 Blue Medical Company Information
10.7.2 Blue Medical Introduction and Business Overview
10.7.3 Blue Medical Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Blue Medical Anti-Restenosis Stents Products Offered
10.7.5 Blue Medical Recent Development
10.8 Boston Scientific
10.8.1 Boston Scientific Company Information
10.8.2 Boston Scientific Introduction and Business Overview
10.8.3 Boston Scientific Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Boston Scientific Anti-Restenosis Stents Products Offered
10.8.5 Boston Scientific Recent Development
10.9 DISA Vascular
10.9.1 DISA Vascular Company Information
10.9.2 DISA Vascular Introduction and Business Overview
10.9.3 DISA Vascular Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.9.4 DISA Vascular Anti-Restenosis Stents Products Offered
10.9.5 DISA Vascular Recent Development
10.10 Essen
10.10.1 Essen Company Information
10.10.2 Essen Introduction and Business Overview
10.10.3 Essen Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Essen Anti-Restenosis Stents Products Offered
10.10.5 Essen Recent Development
10.11 Medtronic Vascular
10.11.1 Medtronic Vascular Company Information
10.11.2 Medtronic Vascular Introduction and Business Overview
10.11.3 Medtronic Vascular Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Medtronic Vascular Anti-Restenosis Stents Products Offered
10.11.5 Medtronic Vascular Recent Development
10.12 MicroPort Medical
10.12.1 MicroPort Medical Company Information
10.12.2 MicroPort Medical Introduction and Business Overview
10.12.3 MicroPort Medical Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.12.4 MicroPort Medical Anti-Restenosis Stents Products Offered
10.12.5 MicroPort Medical Recent Development
10.13 MIV Therapeutics
10.13.1 MIV Therapeutics Company Information
10.13.2 MIV Therapeutics Introduction and Business Overview
10.13.3 MIV Therapeutics Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.13.4 MIV Therapeutics Anti-Restenosis Stents Products Offered
10.13.5 MIV Therapeutics Recent Development
10.14 Orbusneich
10.14.1 Orbusneich Company Information
10.14.2 Orbusneich Introduction and Business Overview
10.14.3 Orbusneich Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Orbusneich Anti-Restenosis Stents Products Offered
10.14.5 Orbusneich Recent Development
10.15 Sahajanand Medical Technologies
10.15.1 Sahajanand Medical Technologies Company Information
10.15.2 Sahajanand Medical Technologies Introduction and Business Overview
10.15.3 Sahajanand Medical Technologies Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Sahajanand Medical Technologies Anti-Restenosis Stents Products Offered
10.15.5 Sahajanand Medical Technologies Recent Development
10.16 J&J/Cordis
10.16.1 J&J/Cordis Company Information
10.16.2 J&J/Cordis Introduction and Business Overview
10.16.3 J&J/Cordis Anti-Restenosis Stents Sales, Revenue and Gross Margin (2018-2023)
10.16.4 J&J/Cordis Anti-Restenosis Stents Products Offered
10.16.5 J&J/Cordis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Restenosis Stents Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Restenosis Stents Industrial Chain Analysis
11.4 Anti-Restenosis Stents Market Dynamics
11.4.1 Anti-Restenosis Stents Industry Trends
11.4.2 Anti-Restenosis Stents Market Drivers
11.4.3 Anti-Restenosis Stents Market Challenges
11.4.4 Anti-Restenosis Stents Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Restenosis Stents Distributors
12.3 Anti-Restenosis Stents Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock